Zobrazeno 1 - 10
of 85
pro vyhledávání: '"Anders A Tveita"'
Autor:
Johanne U. Hermansen, Yanping Yin, Aleksandra Urban, Camilla V. Myklebust, Linda Karlsen, Katrine Melvold, Anders A. Tveita, Kjetil Taskén, Ludvig A. Munthe, Geir E. Tjønnfjord, Sigrid S. Skånland
Publikováno v:
Cell Death Discovery, Vol 9, Iss 1, Pp 1-10 (2023)
Abstract The microenvironment of chronic lymphocytic leukemia (CLL) cells in lymph nodes, spleen, and bone marrow provides survival, proliferation, and drug resistance signals. Therapies need to be effective in these compartments, and pre-clinical mo
Externí odkaz:
https://doaj.org/article/c9d49e1d86744257bcc85e229f404a21
Autor:
Marius Trøseid, José R. Arribas, Lambert Assoumou, Aleksander Rygh Holten, Julien Poissy, Vida Terzić, Fulvia Mazzaferri, Jesús Rodríguez Baño, Joe Eustace, Maya Hites, Michael Joannidis, José-Artur Paiva, Jean Reuter, Isabel Püntmann, Thale D. J. H. Patrick-Brown, Elin Westerheim, Katerina Nezvalova-Henriksen, Lydie Beniguel, Tuva Børresdatter Dahl, Maude Bouscambert, Monika Halanova, Zoltán Péterfi, Sotirios Tsiodras, Michael Rezek, Matthias Briel, Serhat Ünal, Martin Schlegel, Florence Ader, Karine Lacombe, Cecilie Delphin Amdal, Serge Rodrigues, Kristian Tonby, Alexandre Gaudet, Lars Heggelund, Joy Mootien, Asgeir Johannessen, Jannicke Horjen Møller, Beatriz Diaz Pollan, Anders Aune Tveita, Anders Benjamin Kildal, Jean-Christophe Richard, Olav Dalgard, Victoria Charlotte Simensen, Aliou Baldé, Lucie de Gastines, Marta del Álamo, Burç Aydin, Fridtjof Lund-Johansen, Mary-Anne Trabaud, Alpha Diallo, Bente Halvorsen, John-Arne Røttingen, Evelina Tacconelli, Yazdan Yazdanpanah, Inge C. Olsen, Dominique Costagliola, EU SolidAct study group
Publikováno v:
Critical Care, Vol 27, Iss 1, Pp 1-15 (2023)
Abstract Background Baricitinib has shown efficacy in hospitalized patients with COVID-19, but no placebo-controlled trials have focused specifically on severe/critical COVID, including vaccinated participants. Methods Bari-SolidAct is a phase-3, mul
Externí odkaz:
https://doaj.org/article/10e2b9214bb042eab664227ef6ea4d9d
Publikováno v:
Mobile DNA, Vol 13, Iss 1, Pp 1-16 (2022)
Abstract Background Mobile group I introns encode homing endonucleases that confer intron mobility initiated by a double-strand break in the intron-lacking allele at the site of insertion. Nuclear ribosomal DNA of some fungi and protists contain mobi
Externí odkaz:
https://doaj.org/article/87bd7cf93d3c45e2b8ec62bdaa2aa6e5
Autor:
Marius Myrstad, Håkon Ihle-Hansen, Anders Aune Tveita, Elizabeth Lyster Andersen, Ståle Nygård, Arnljot Tveit, Trygve Berge
Publikováno v:
Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine, Vol 28, Iss 1, Pp 1-8 (2020)
Abstract Background There is a need for validated clinical risk scores to identify patients at risk of severe disease and to guide decision-making during the covid-19 pandemic. The National Early Warning Score 2 (NEWS2) is widely used in emergency me
Externí odkaz:
https://doaj.org/article/2998d71001454eadbfc67ab9630e9316
Autor:
Thor Ueland, Lauri A.O. Äikäs, Tuva B. Dahl, Ida Gregersen, Maria Belland Olsen, Annika Michelsen, Ylva Schanke, Minna Holopainen, Hanna Ruhanen, Sachin Singh, Anders Aune Tveita, Ane-Kristine Finbråten, Lars Heggelund, Marius Trøseid, Anne Ma Dyrhol-Riise, Tuula A. Nyman, Kirsten B. Holven, Katariina Öörni, Pål Aukrust, Bente Halvorsen
Publikováno v:
Journal of Infection. 86:489-492
Autor:
Ida Gregersen, Thor Ueland, Jan Cato Holter, Maria Belland Olsen, Annika E Michelsen, Sarah L Murphy, Anders Aune Tveita, Katerina Nezvalova Henriksen, Hedda Hoel, Lena Bugge Nordberg, Aleksander Rygh Holten, Thor Edvardsen, Kuan Yang, Lars Heggelund, Marius Trøseid, Fredrik Müller, Anders Benjamin Kildal, Anne Ma Dyrhol-Riise, Andreas Barratt-Due, Tuva B Dahl, Pål Aukrust, Bente Halvorsen
Publikováno v:
Journal of Infection. 85:702-769
Autor:
Signe Søvik, Andreas Barratt-Due, Trine Kåsine, Theresa Olasveengen, Marianne Wigernes Strand, Anders Aune Tveita, Jan Erik Berdal, Martin Andreas Lehre, Torleif Lorentsen, Lars Heggelund, Tore Stenstad, Jetmund Ringstad, Fredrik Müller, Pål Aukrust, Jan Cato Holter, Ingvild Nordøy
Publikováno v:
Journal of Infection
Objectives To determine the incidence and characteristics of superinfections in mechanically ventilated COVID-19 patients, and the impact of dexamethasone as standard therapy. Methods This multicentre, observational, retrospective study included pati
Autor:
Ronald Levy, Paul A. Wender, Robert M. Waymouth, Adrienne Sallets, Anders A. Tveita, Colin J. McKinlay, Timothy R. Blake, Ole Audun Werner Haabeth
OX40L, CD80 and CD86 mRNA-CART treatment increased the expression of CD80, CD86 and OX40L protein on tumor infiltrating cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e930294fe3e506b8c8b7e415ac16e1f5
https://doi.org/10.1158/0008-5472.22422302
https://doi.org/10.1158/0008-5472.22422302
Autor:
Ronald Levy, Paul A. Wender, Robert M. Waymouth, Adrienne Sallets, Anders A. Tveita, Colin J. McKinlay, Timothy R. Blake, Ole Audun Werner Haabeth
Localized expression of effector molecules can initiate antitumor responses through engagement of specific receptors on target cells in the tumor microenvironment. These locally induced responses may also have a systemic effect, clearing additional t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b35adde64007d6fb68bfae2143b49ed9
https://doi.org/10.1158/0008-5472.c.6511175
https://doi.org/10.1158/0008-5472.c.6511175
Autor:
Ronald Levy, Paul A. Wender, Robert M. Waymouth, Adrienne Sallets, Anders A. Tveita, Colin J. McKinlay, Timothy R. Blake, Ole Audun Werner Haabeth
Supplementary Figure S2. OX40L, CD80 and CD86 mRNA-CART treatment induce long lasting protection against re-challenge with the same tumor cell line. Supplementary Figure S3. OX40L, CD80 and CD86 mRNA-CART treatment do not result in long term elevated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0194fcd4d92fb36342de29c74ad03b3b
https://doi.org/10.1158/0008-5472.22422305
https://doi.org/10.1158/0008-5472.22422305